The presentation highlighted tolebrutinib’s potential as the first Bruton’s tyrosine kinase (BTK) inhibitor to receive regulatory approval for the treatment of progressive MS. During the Clinical ...

Still, more research is needed, and there's little known about how one CGRP inhibitor performs when compared with another CGRP drug. Aimovig, Ajovy, and Emgality are taken via subcutaneous injection.

He must be the catalyst and not an inhibitor. All his actions must be impelled, keeping in mind the dignity of the high constitutional office.” India needs fair, non-hyphenated and questioning ...

Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the ...

A once-daily oral PCSK9 inhibitor reduced LDL in patients with hypercholesterolemia. Safety and tolerability profiles were favorable, according to investigators. CHICAGO — In a phase 2b study ...

Palbociclib, a well-tolerated and selective CDK4/6 inhibitor, has shown promising results in the treatment of retinoblastoma (RB1)-positive breast cancer. RB1 is rarely mutated in HCC, suggesting that ...

Although horny goat weed contains icariin, a mild PDE5 inhibitor, it's unclear how horny goat weed interacts with nitrate-containing medications due to the lack of studies on such safety concerns.

1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan. 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Harbin Medical ...

If you have type 2 diabetes, it’s possible that you may be prescribed an SGLT2 inhibitor along with another diabetes medication like metformin. A doctor can let you know more about the potential ...

Introduction: Cisplatin-induced acute kidney injury (AKI) is primarily caused by oxidative stress from reactive oxygen species (ROS) accumulation. Developing ROS scavengers presents promising ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Researchers from the University of Queensland recently provided details on the discovery and preclinical characterization of a new hematopoietic prostaglandin D2 synthase (HPGDS) inhibitor, CLS-189, ...